UŽDAROJI AKCINĖ BENDROVĖ "NARMEDOS MEDICINA" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 313,334 |
| 20,254 |
| 4,514 |
| 4,278 |
| 277 |
| 36.96 |
| 1.37 |
| 521,479 |
| 128,788 |
| 224,220 |
| 425,379 |
| 2024 |
|---|
| 299,662 |
| 19,858 |
| 15,848 |
| 15,135 |
| 1,003 |
| 36.39 |
| 5.05 |
| 536,614 |
| 40,594 |
| 206,801 |
| 369,893 |
| 2025 |
|---|
| 376,718 |
| 27,659 |
| 29,184 |
| 27,006 |
| 1,983 |
| 90.50 |
| 7.17 |
| 458,444 |
| 151,221 |
| 161,216 |
| 447,563 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 376,718 |
| 27,659 |
| 29,184 |
| 27,006 |
| 1,983 |
| 90.50 |
| 7.17 |
| 458,444 |
| 151,221 |
| 161,216 |
| 447,563 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
376,718 €26 % *
Sales per employee (€)
27,659 €39 % *
Profit before tax (€)
29,184 €84 % *
Net Profit (€)
27,006 €78 % *
Profit per employee (€)
1,983 €98 % *
Total profitability (%)
90.50 %148.69 % *
Net profitability (%)
7.17 %41.98 % *
Equity (€)
458,444 €-15 % *
Amounts Payable And Liabilities (€)
151,221 €273 % *
Non-current Assets (€)
161,216 €-22 % *
CurrentAssets (€)
447,563 €21 % *
